Phase 1 · Understand the Body — Why the disease behaves the way it does.
The One-Line Truth
The whole disease in one chain
Everything on this page exists to explain this line.
Cirrhosis creates a rebalanced but fragile coagulation system where both clotting and bleeding risks coexist because the liver can no longer make normal amounts of pro-clotting and anti-clotting proteins.
A Factory Making Opposing Teams
Imagine a factory (the liver) that employs two rival teams: the Builders who repair broken pipes (clotting factors like II, V, VII, IX, X) and the Inspectors who prevent over-repair (anticoagulant proteins like protein C and antithrombin). In a healthy factory, both teams show up in equal strength every day, so pipes get fixed without blocking. When cirrhosis hits, scar tissue destroys the factory's production lines, so fewer Builders AND fewer Inspectors arrive for work each day. The system rebalances—the remaining Builders work faster, and some Inspectors call in sick, so clots still form okay in quiet times. But when a big pipe breaks (variceal bleed) or a crisis hits (infection), you suddenly need a full crew and don't have one, so the balance collapses and bleeding runs wild. Meanwhile, the factory's slow-flow drainage system (portal vein) gets clogged by scar tissue, causing backup that swells the warehouse (spleen) where tools (platelets) get stuck and lost.
American Association for the Study of Liver Diseases (AASLD) guidelines on complications of cirrhosis, including management of coagulation disorders and variceal bleeding (2016-2021) · American Society of Hematology (ASH) guidelines on plasma transfusion and platelet transfusion in adults (2021) · Baveno VII Consensus Workshop on portal hypertension and variceal bleeding management (2022) · Northup PG, et al. Coagulation in liver disease: a guide for the clinician. Clinical Gastroenterology and Hepatology (2013) on rebalanced hemostasis in cirrhosis · reviewed 2026-08-29